OWKIN
Contact information
- Biomarkers
- Drug development
- Drug discovery
- Screening
- Gene Therapy
- Cardiovascular diseases and circulatory system
- Inflammatory diseases
- Immunology
- Oncology
- Bioinformatics
- Genomics
- Metabolomics
- Proteomics
Owkin is a full-stack TechBio company on a mission to understand complex biology and derive new multimodal biomarkers through AI.
By developing a cutting-edge federated learning framework while simultaneously building the world´s biggest network of hospitals, KOLs and high-quality, multimodal datatest, we are focused on making long-term, transformative improvements to medical research and drug development.
We merge wet lab experiments with advanced AI techniques to create a powerful feedback loop for accelerated discovery and innovation in oncology, cardiovascular, inmunity and inflammation.
We identify precision therapeutics, de-risk and accelerate clinical trials and develop diagnostics using AI trained on world-class patient data through privacy-enhancing technologies.
- Oncology
- Cardiovascular
- I&I
- AI
- Drug Discovery & Development
- Target indentification and key biomarkers
- Patient molecular subtyping